Prot# GS-US-337-1431:A Registry for Subjects with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection in Gilead-Sponsored Trials

Project: Research project

Project Details

StatusActive
Effective start/end date4/13/154/13/22

Funding

  • Duke Clinical Research Institute (GS-US-337-1431)
  • Gilead Sciences, Inc. (GS-US-337-1431)